Free Trial
NASDAQ:VAXX

Vaxxinity (VAXX) Stock Price, News & Analysis

Vaxxinity logo
$0.0001 -0.01 (-99.00%)
As of 10/9/2025 02:01 PM Eastern

About Vaxxinity Stock (NASDAQ:VAXX)

Advanced

Key Stats

Today's Range
$0.00
$0.02
50-Day Range
$0.00
$0.04
52-Week Range
$0.00
$0.07
Volume
2,824 shs
Average Volume
7,037 shs
Market Capitalization
$12.67 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive VAXX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vaxxinity and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VAXX Stock News Headlines

Brain health
Treatment Trials in Alzheimer's Disease
Building The Infrastructure for the Coming Financial Reset
While China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly building the infrastructure for decentralized AI and asset-backed tokens — and its latest $90M acquisition move could make it a critical player in the next financial reset.tc pixel
Why Is Vaxxinity (VAXX) Stock Up 39% Today?
Why Is Vaxxinity (VAXX) Stock Down 58% Today?
Vaxxinity Plans to Delist Shares From Nasdaq
Vaxxinity Issues Shareholder Letter
See More Headlines

VAXX Stock Analysis - Frequently Asked Questions

Vaxxinity's stock was trading at $0.0050 at the start of the year. Since then, VAXX stock has decreased by 98.0% and is now trading at $0.0001.

Vaxxinity, Inc. (NASDAQ:VAXX) posted its earnings results on Monday, March, 27th. The company reported ($0.16) EPS for the quarter, hitting the consensus estimate of ($0.16).

Vaxxinity (VAXX) raised $90 million in an IPO on Thursday, November 11th 2021. The company issued 6,000,000 shares at a price of $14.00-$16.00 per share.

Shares of VAXX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vaxxinity investors own include Meta Platforms (META), NVIDIA (NVDA), Taiwan Semiconductor Manufacturing (TSM), Avino Silver & Gold Mines (ASM), Rivian Automotive (RIVN), Tesla (TSLA) and JPMorgan Chase & Co. (JPM).

Company Calendar

Last Earnings
3/27/2023
Today
10/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:VAXX
CIK
1851657
Fax
N/A
Employees
90
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.11 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
126,748,000
Free Float
45,553,000
Market Cap
$12.67 thousand
Optionable
Not Optionable
Beta
17.10
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:VAXX) was last updated on 10/10/2025 by MarketBeat.com Staff
From Our Partners